Fundraising Fox
/People
Sign in

Glenn Short

Investor

Chief Scientific Officer at atai Life Sciences

Boston, Massachusetts, United States

Find your path to Glenn

346 people in our graph can introduce you to Glenn.

Each arrow is one introduction. Sign up to fill in the first one.

Ask John McCabe to introduce you to Glenn

You →John · together at Flex Pharma (2014–2019) →Glenn

Ask Jamie Chen to introduce you to Glenn

You →Jamie · together at Axial Biotherapeutics, Inc. →Glenn

Ask Sam Okafor to introduce you to Glenn

You →Sam · 10 people · together at Massachusetts General Hospital →Glenn

Sign up to find every way you can get introduced to Glenn

  • Your email: the people you already email who know Glenn
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Glenn
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Glenn Short is Chief Scientific Officer at atai Life Sciences, a role he took in 2025 after serving as Senior Vice President of Early Development from 2022. He leads internal innovation and early-stage product development, integrating translational medicine into development and clinical strategies, and has over 20 years of industry and research experience across venture-backed and public companies. He holds a Ph.D. in Chemistry from the University of Virginia and completed postdoctoral training in molecular biology at Massachusetts General Hospital/Harvard Medical School.

Experience

  1. Viridia Life SciencesBoard Member2022 — 2023
  2. Viridia Life SciencesChief Executive Officer2020 — 2022
  3. EmpathBioBoard Member2022 — 2023
  4. EmpathBioChief Executive Officer2020 — 2022
  5. EntheogeniX BiosciencesChief Executive Officer2022 — 2023
  6. EntheogeniX BiosciencesChief Scientific Officer2019 — 2022
  7. Glenn Short ConsultingSenior Biotech and Pharmaceutical R&D Consultant2019
  8. Axial Biotherapeutics, Inc.VP, Early Development2019
  9. Flex PharmaVP level, Pharmaceutical R&D Consultant2018 — 2019
  10. Flex PharmaVP, Research and Translational Development2017 — 2018
  11. Flex PharmaVP, Nonclinical and Translational Research2017
  12. Flex PharmaSenior Director, Research2014 — 2017
  13. BiotechnologyBiotechnology Consultant2014
  14. Zalicus IncorporatedSenior Director, Research2012 — 2013cambridge, ma
  15. Zalicus IncorporatedDirector of Discovery Sciences2009 — 2012Cambridge, MA
  16. CombinatoRx, Inc.Team Leader in Discovery Biology2007 — 2009Cambridge, MA
  17. CombinatoRx, Inc.Senior Scientist in Platform/Technology Development2005 — 2007Cambridge, MA
  18. Massachusetts General HospitalAssociate Biologist2002 — 2005
  19. Harvard Medical SchoolHoward Hughes Postdoctoral Scientist in Molecular Biology1999 — 2002Department of Molecular Biology, Massachusetts General Hospital

Skills & more

C Level ManagementC-LevelC SuiteLeadership1Molecular Biology15Drug Development17Drug Discovery22Primary PharmacologyMolecular & Cellular Biology2Ion Channel Biology involved in Pain SignalingMolecular Immunology1IND & CTD Preparation
+12 moreMedicinal ChemistryMolecular ModelingHigh Throughput ScreeningMolecular OncologyChemical GenomicsResearch Program ManagementVirtual Program ManagementResearch ProjectsCommunicationGenomicsAssay DevelopmentBiotechnology

From Glenn's professional profile.

Colleagues at atai Life Sciences

Amir Kalali
Director at atai Life Sciences
Andrea Heslin Smiley
Director at atai Life Sciences
Anne Johnson
Chief Accounting Officer at atai Life Sciences
Christian Angermayer
Founder and Chairman of the Board at atai Life Sciences
Gerd Kochendoerfer
Chief Operating Officer at atai Life Sciences
John Hoffman
Director at atai Life Sciences
Kevin Craig
Chief Medical Officer at atai Life Sciences
Laurent Fischer
Director at atai Life Sciences

Frequently asked questions

Who is Glenn Short?
Glenn Short is Chief Scientific Officer at atai Life Sciences, a role he took in 2025 after serving as Senior Vice President of Early Development from 2022. He leads internal innovation and early-stage product development, integrating translational medicine into development and clinical strategies, and has over 20 years of industry and research experience across venture-backed and public companies. He holds a Ph.D. in Chemistry from the University of Virginia and completed postdoctoral training in molecular biology at Massachusetts General Hospital/Harvard Medical School.
Where does Glenn Short work?
Glenn Short is Chief Scientific Officer at atai Life Sciences.
Where did Glenn Short go to school?
Glenn Short studied at University of Virginia (PhD, Chemistry); University of Virginia (BA, Chemistry).

Same school

Shared employers